Avon Research Facility for Sale Through Regeneron

Jones Lang LaSalle Inc., or JLL, a global commercial real estate firm, has announced that it has been exclusively retained to market 1 Avon Place, a 235,000-square-foot Class A research and development facility in Suffern, New York, for sale and/or lease on behalf of Westchester County-based biotechnology company Regeneron.

The three-story property, which was the former innovation center for global beauty brand Avon, is purpose-built for research and development and offers a highly flexible layout supported by existing lab, office and technical infrastructure. The site has flexible zoning that allows for a broad range of uses and future redevelopment potential, including continued research and development use as well as conversion to healthcare, data center and other permitted uses, positioning the asset to appeal to a wide spectrum of owner-users, investors and tenants.

Situated on nearly 10 acres, 1 Avon Pl. is fully equipped with institutional-grade infrastructure, including 34 fume hoods, DI water, compressed air and vacuum systems, natural gas to bench tops, a gas detection system, dual 900-ton chillers, 4,000 amps of total power and a 750-kilowatt emergency generator. Existing uses span clinical testing, pilot plant operations, microbiology and analytical labs, executive offices and technical service areas, offering immediate usability for life sciences, biotech and R&D users.

The Suffern submarket is rapidly growing, with over 400 residential units built or proposed since 2023 as well as an expanding medical market. The property features 565 parking spaces, 75,000-square-foot floor plates, a glass atrium lobby, 15.5-foot slab-to-slab heights, 24/7 gated security and three covered loading docks. The basement level serves as a hub for technical service operations. 

The JLL team marketing the property is being led by Vice Chairman Dan Loughlin, Senior Managing Director Jeremy Neuer and Vice President Matt Loughlin.

“Properties of this scale and quality rarely come to market in Rockland County,” said Dan Loughlin. “1 Avon Place offers a compelling combination of best-in-class infrastructure, flexible zoning and exceptional regional access. Whether for an owner-user seeking an R&D environment, an investor pursuing long-term value or a tenant looking to establish a flagship facility, this asset provides multiple paths to execution.”

Added Neuer, “We are seeing strong investor demand across the life science sector. This opportunity stands out among the region’s inventory due to the original developer’s significant investment in high-quality construction, creating a turnkey environment that is increasingly difficult to replicate in today’s market.”

Rockland County’s R&D and life sciences sectors are part of a diversified economic base, with targeted growth in biotech, advanced manufacturing and healthcare industries, supported by increased interest from firms seeking proximity to the NYC market and major highway infrastructure. Demand from professional services, healthcare and flex users seeking to adapt space to hybrid work and operational needs continues to buoy the Class A/B office market.